This occurred in a similar fashion, suggesting that the genetic make-up of these tumor cells likely does not contribute to the efficacy of the combination treatment in light of the fact that U87 are wild type TP53, whereas in contrast LN229 are mutated. Here, TP53 is linked to neoplasm.